Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × sintilimab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

sintilimab 1 pembrolizumab 1 Whole Genome Sequencing 1 Sequence Analysis, RNA 1 Magnetic Resonance Spectroscopy 1 Fluorodeoxyglucose F18 1 FAPI-46 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

M.D. Anderson Cancer Center

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡